Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma

por Janjetovic, Snjezana, Augustyniak, Jaroslaw Wojciech, Darb‐Esfahani, Silvia, Baumann, Clemens, Fuhrmann, Stephan
Publicado 2021

PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Che...

por Guo, Sanxing, Loibl, Sibylle, von Minckwitz, Gunter, Darb-Esfahani, Silvia, Lederer, Bianca, Denkert, Carsten
Publicado 2020

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

por Pietzner, Klaus, Nasser, Sara, Alavi, Sara, Darb-Esfahani, Silvia, Passler, Mona, Muallem, Mustafa Zelal, Sehouli, Jalid
Publicado 2018

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

por Budczies, Jan, Klauschen, Frederick, Sinn, Bruno V., Győrffy, Balázs, Schmitt, Wolfgang D., Darb-Esfahani, Silvia, Denkert, Carsten
Publicado 2012

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

por Noske, Aurelia, Schwabe, Michael, Weichert, Wilko, Darb-Esfahani, Silvia, Buckendahl, Ann-Christin, Sehouli, Jalid, Braicu, Elena I, Budczies, Jan, Dietel, Manfred, Denkert, Carsten
Publicado 2011

Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration

por Mayer, Christine, Darb-Esfahani, Silvia, Meyer, Anne-Sophie, Hübner, Katrin, Rom, Joachim, Sohn, Christof, Braicu, Ioana, Sehouli, Jalid, Hänsch, G. Maria, Gaida, Matthias M.
Publicado 2016

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

por Woopen, Hannah, Pietzner, Klaus, Richter, Rolf, Fotopoulou, Christina, Joens, Thomas, Braicu, Elena Ioana, Mellstedt, Håkan, Mahner, Sven, Lindhofer, Horst, Darb-Esfahani, Silvia, Denkert, Carsten, Sehouli, Jalid
Publicado 2014

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

por Darb-Esfahani, Silvia, Kunze, Catarina Alisa, Kulbe, Hagen, Sehouli, Jalid, Wienert, Stephan, Lindner, Judith, Budczies, Jan, Bockmayr, Michael, Dietel, Manfred, Denkert, Carsten, Braicu, Ioana, Jöhrens, Korinna
Publicado 2015

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

por Lehmann, Annika, Denkert, Carsten, Budczies, Jan, Buckendahl, Ann-Christin, Darb-Esfahani, Silvia, Noske, Aurelia, Müller, Berit Maria, Bahra, Marcus, Neuhaus, Peter, Dietel, Manfred, Kristiansen, Glen, Weichert, Wilko
Publicado 2009

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer

por Patel, Jai N., Braicu, Ioana, Timms, Kirsten M., Solimeno, Cara, Tshiaba, Placede, Reid, Julia, Lanchbury, Jerry S., Darb-Esfahani, Silvia, Ganapathi, Mahrukh K., Sehouli, Jalid, Ganapathi, Ram N.
Publicado 2018

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer

por Kulbe, Hagen, Otto, Raik, Darb-Esfahani, Silvia, Lammert, Hedwig, Abobaker, Salem, Welsch, Gabriele, Chekerov, Radoslav, Schäfer, Reinhold, Dragun, Duska, Hummel, Michael, Leser, Ulf, Sehouli, Jalid, Braicu, Elena Ioana
Publicado 2019

High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism

por Braicu, Elena Ioana, Darb-Esfahani, Silvia, Schmitt, Wolfgang D., Koistinen, Kaisa M., Heiskanen, Laura, Pöhö, Päivi, Budczies, Jan, Kuhberg, Marc, Dietel, Manfred, Frezza, Christian, Denkert, Carsten, Sehouli, Jalid, Hilvo, Mika
Publicado 2017

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging

por Kulbe, Hagen, Klein, Oliver, Wu, Zhiyang, Taube, Eliane T., Kassuhn, Wanja, Horst, David, Darb-Esfahani, Silvia, Jank, Paul, Abobaker, Salem, Ringel, Frauke, du Bois, Andreas, Heitz, Florian, Sehouli, Jalid, Braicu, Elena I.
Publicado 2020

Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment

por Hoffmann, Karen, Berger, Hilmar, Kulbe, Hagen, Thillainadarasan, Sukanija, Mollenkopf, Hans‐Joachim, Zemojtel, Tomasz, Taube, Eliane, Darb‐Esfahani, Silvia, Mangler, Mandy, Sehouli, Jalid, Chekerov, Radoslav, Braicu, Elena I, Meyer, Thomas F, Kessler, Mirjana
Publicado 2020

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium

por Aust, Stefanie, Bachmayr-Heyda, Anna, Pateisky, Petra, Tong, Dan, Darb-Esfahani, Silvia, Denkert, Carsten, Chekerov, Radoslav, Sehouli, Jalid, Mahner, Sven, Van Gorp, Toon, Vergote, Ignace, Speiser, Paul, Horvat, Reinhard, Zeillinger, Robert, Pils, Dietmar
Publicado 2012

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer

por Ihlow, Jana, Monjé, Nanna, Hoffmann, Inga, Bischoff, Philip, Sinn, Bruno Valentin, Schmitt, Wolfgang Daniel, Kunze, Catarina Alisa, Darb-Esfahani, Sylvia, Kulbe, Hagen, Braicu, Elena Ioana, Sehouli, Jalid, Denkert, Carsten, Horst, David, Taube, Eliane Tabea
Publicado 2022

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

por Darb-Esfahani, S, Kronenwett, R, von Minckwitz, G, Denkert, C, Gehrmann, M, Rody, A, Budczies, J, Brase, J C, Mehta, M K, Bojar, H, Ataseven, B, Karn, T, Weiss, E, Zahm, D M, Khandan, F, Dietel, M, Loibl, S
Publicado 2012

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

por Darb-Esfahani, Silvia, von Minckwitz, Gunter, Denkert, Carsten, Ataseven, Beyhan, Högel, Bernhard, Mehta, Keyur, Kaltenecker, Gabriele, Rüdiger, Thomas, Pfitzner, Berit, Kittel, Kornelia, Fiedler, Bettina, Baumann, Klaus, Moll, Roland, Dietel, Manfred, Eidtmann, Holger, Thomssen, Christoph, Loibl, Sibylle
Publicado 2014

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with...

por Darb-Esfahani, Silvia, Loibl, Sibylle, Müller, Berit M, Roller, Marc, Denkert, Carsten, Komor, Martina, Schlüns, Karsten, Blohmer, Jens Uwe, Budczies, Jan, Gerber, Bernd, Noske, Aurelia, du Bois, Andreas, Weichert, Wilko, Jackisch, Christian, Dietel, Manfred, Richter, Klaus, Kaufmann, Manfred, von Minckwitz, Gunter
Publicado 2009

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

por Denkert, Carsten, Huober, Jens, Loibl, Sibylle, Prinzler, Judith, Kronenwett, Ralf, Darb-Esfahani, Silvia, Brase, Jan C, Solbach, Christine, Mehta, Keyur, Fasching, Peter A, Sinn, Bruno V, Engels, Knut, Reinisch, Mattea, Hansmann, Martin-Leo, Tesch, Hans, von Minckwitz, Gunter, Untch, Michael
Publicado 2013